Texas Oncology-Austin Midtown ( Site 8002) — Austin, Texas

Texas Oncology-Austin Midtown ( Site 8002) is a clinical research site located in Austin, Texas, United States 78705.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Texas Oncology-Austin Midtown ( Site 8002) has participated in 1 clinical trials.

Therapeutic areas: Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Austin Midtown ( Site 8002)?

Texas Oncology-Austin Midtown ( Site 8002) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Austin Midtown ( Site 8002) conducted?

Texas Oncology-Austin Midtown ( Site 8002) has 1 clinical trials on record. Their work covers Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell.

Is Texas Oncology-Austin Midtown ( Site 8002) accredited by Crixeo Health?

Texas Oncology-Austin Midtown ( Site 8002) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology-Austin Midtown ( Site 8002)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.